For the year ending 2025-12-31, IRD made $14,196K in revenue. -$49,591K in net income. Net profit margin of -349.33%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| License and collaborations revenue | 14,196 | 10,992 | ||
| Research and development | 30,812 | 26,851 | ||
| General and administrative | 21,983 | 18,215 | ||
| Acquired in-process research and development | 0 | 28,000 | ||
| Total operating expenses | 52,795 | 73,066 | ||
| Loss from operations | -38,599 | -62,074 | ||
| Fair value change in warrant and other derivative liabilities | -11,515 | 72 | ||
| Financing costs (note 7) | 1,337 | - | ||
| Interest expense | 129 | - | ||
| Other income, net | 1,989 | 4,470 | ||
| Loss before income taxes | -49,591 | -57,532 | ||
| Provision for income taxes | 0 | - | ||
| Net loss | -49,591 | -57,532 | ||
| Other comprehensive loss, net of tax | 0 | - | ||
| Comprehensive loss | -49,591 | -57,532 | ||
| Basic EPS | -0.8 | -2.15 | ||
| Diluted EPS | -0.8 | -2.15 | ||
| Basic Average Shares | 62,221,901 | 26,715,526 | ||
| Diluted Average Shares | 62,221,901 | 26,715,526 | ||
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD)